Selected research
Industry Research
Enteric-coated Tablets Industry Research Report 2026
Market perspective
The global Enteric-coated Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Enteric-coated Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Enteric-coated Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Enteric-coated Tablets include Boehringer Ingelheim, Dr. Reddy's Laboratories, Weidar Chemical & Pharmaceutical, AstraZeneca, Bayer, GSK, Novartis and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Enteric-coated Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Enteric-coated Tablets Market by Company
Boehringer Ingelheim
Dr. Reddy's Laboratories
Weidar Chemical & Pharmaceutical
AstraZeneca
Bayer
GSK
Novartis
Takeda
Enteric-coated Tablets Segment by Type
Bisacodyl
Serrapeptase
Pantoprazole Sodium
Esomeprazole Magnesium
Aspirin
Enteric-coated Tablets Segment by Application
Hospital
Clinic
Enteric-coated Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enteric-coated Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enteric-coated Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enteric-coated Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Enteric-coated Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Enteric-coated Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Enteric-coated Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bisacodyl
- Serrapeptase
- Pantoprazole Sodium
- Esomeprazole Magnesium
- Aspirin
Applications
- Hospital
- Clinic
Companies covered
- Boehringer Ingelheim
- Dr. Reddy's Laboratories
- Weidar Chemical & Pharmaceutical
- AstraZeneca
- Bayer
- GSK
- Novartis
- Takeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Enteric-coated Tablets Market Size (2021-2032)
- 2.2.2 Global Enteric-coated Tablets Sales (2021-2032)
- 2.2.3 Global Enteric-coated Tablets Market Average Price (2021-2032)
- 2.3 Enteric-coated Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bisacodyl
- 2.3.3 Serrapeptase
- 2.3.4 Pantoprazole Sodium
- 2.3.5 Esomeprazole Magnesium
- 2.3.6 Aspirin
- 2.4 Enteric-coated Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Enteric-coated Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Enteric-coated Tablets Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Enteric-coated Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Enteric-coated Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Enteric-coated Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Enteric-coated Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Enteric-coated Tablets, Product Type & Application
- 3.8 Global Manufacturers of Enteric-coated Tablets, Established Date
- 3.9 Global Enteric-coated Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Enteric-coated Tablets Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 Dr. Reddy's Laboratories
- 4.2.1 Dr. Reddy's Laboratories Company Information
- 4.2.2 Dr. Reddy's Laboratories Business Overview
- 4.2.3 Dr. Reddy's Laboratories Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dr. Reddy's Laboratories Enteric-coated Tablets Product Portfolio
- 4.2.5 Dr. Reddy's Laboratories Recent Developments
- 4.3 Weidar Chemical & Pharmaceutical
- 4.3.1 Weidar Chemical & Pharmaceutical Company Information
- 4.3.2 Weidar Chemical & Pharmaceutical Business Overview
- 4.3.3 Weidar Chemical & Pharmaceutical Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Weidar Chemical & Pharmaceutical Enteric-coated Tablets Product Portfolio
- 4.3.5 Weidar Chemical & Pharmaceutical Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Enteric-coated Tablets Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Enteric-coated Tablets Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Enteric-coated Tablets Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 Novartis
- 4.7.1 Novartis Company Information
- 4.7.2 Novartis Business Overview
- 4.7.3 Novartis Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novartis Enteric-coated Tablets Product Portfolio
- 4.7.5 Novartis Recent Developments
- 4.8 Takeda
- 4.8.1 Takeda Company Information
- 4.8.2 Takeda Business Overview
- 4.8.3 Takeda Enteric-coated Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Takeda Enteric-coated Tablets Product Portfolio
- 4.8.5 Takeda Recent Developments
5 Global Enteric-coated Tablets Market Scenario by Region
- 5.1 Global Enteric-coated Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Enteric-coated Tablets Sales by Region: 2021-2032
- 5.2.1 Global Enteric-coated Tablets Sales by Region: 2021-2026
- 5.2.2 Global Enteric-coated Tablets Sales by Region: 2027-2032
- 5.3 Global Enteric-coated Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Enteric-coated Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Enteric-coated Tablets Revenue by Region: 2027-2032
- 5.4 North America Enteric-coated Tablets Market Facts & Figures by Country
- 5.4.1 North America Enteric-coated Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Enteric-coated Tablets Sales by Country (2021-2032)
- 5.4.3 North America Enteric-coated Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Enteric-coated Tablets Market Facts & Figures by Country
- 5.5.1 Europe Enteric-coated Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Enteric-coated Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Enteric-coated Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Enteric-coated Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Enteric-coated Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Enteric-coated Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Enteric-coated Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Enteric-coated Tablets Market Facts & Figures by Country
- 5.7.1 South America Enteric-coated Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Enteric-coated Tablets Sales by Country (2021-2032)
- 5.7.3 South America Enteric-coated Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Enteric-coated Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Enteric-coated Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Enteric-coated Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Enteric-coated Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Enteric-coated Tablets Sales by Type (2021-2032)
- 6.1.1 Global Enteric-coated Tablets Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Enteric-coated Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Enteric-coated Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Enteric-coated Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Enteric-coated Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Enteric-coated Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Enteric-coated Tablets Sales by Application (2021-2032)
- 7.1.1 Global Enteric-coated Tablets Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Enteric-coated Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Enteric-coated Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Enteric-coated Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Enteric-coated Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Enteric-coated Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Enteric-coated Tablets Value Chain Analysis
- 8.1.1 Enteric-coated Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Enteric-coated Tablets Production Mode & Process
- 8.2 Enteric-coated Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Enteric-coated Tablets Distributors
- 8.2.3 Enteric-coated Tablets Customers
9 Global Enteric-coated Tablets Analyzing Market Dynamics
- 9.1 Enteric-coated Tablets Industry Trends
- 9.2 Enteric-coated Tablets Industry Drivers
- 9.3 Enteric-coated Tablets Industry Opportunities and Challenges
- 9.4 Enteric-coated Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst